KospicyKorean filings in English
Filings / TC Materials Co., Ltd.

Beneficial Ownership Report (5%) — Standard Form

TC Materials Co., Ltd. · 주식등의대량보유상황보고서(일반)

SC 13D/GKOSDAQ · 125020 Filed 2026-11-20Korean original on DART

English form view 77% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Report on large shareholdings (general)

6.1

티씨머티리얼즈㈜

1101

1000

20261117

Report on Large Holdings of Shares, etc.

(General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control)
To: Financial Services CommissionReporting obligation date:2026-11-17
To: Korea ExchangeReport reference date:2026-11-17
Reporting person:㈜바이오스마트
Summary
Issuer name티씨머티리얼즈㈜Relationship to IssuerLargest Shareholder
Report TypeChange
Number of Shares Held and Holding RatioNumber of Shares HeldHolding Ratio
Previous Report17,598,89550.23
Current Report20,200,35153.67
Shares under key agreements: number and ratioNumber of shares, etc.Ratio
Previous Report--
Current Report--
Number of voting rights and holding ratioNumber of Voting RightsHolding Ratio
Previous Report--
Current Report--
Voting rights under key agreements: number and ratioNumber of Voting RightsRatio
Previous Report--
Current Report--
Reason for Report보고자 및 특별관계자의 제3자배정 유상증자 참여에 따른 보유 주식 수 변동
※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission.

Part 1 Report Overview

1. Issuer information

Company Name티씨머티리얼즈㈜Company code125020
Entity typeKOSDAQ-Listed CompanyTotal Issued Voting Shares (shares)37,640,006

※ 상기 발행주식 총수는 유상증자로 발행될 신주(2,601,456주)를 반영한 수치입니다.

2. Major shareholder information

a. Reporting person

(1) Reporting person overview

Report TypeChangeJoint signatories
Reporting person typeDomestic corporationNationalityRepublic of Korea
Basis for Reporter Classification (only if reported as a statutory partnership or other entity)-
Name (Entity Name)Korean㈜바이오스마트Chinese characters (English)BioSmart Co.,Ltd.
Address (Head Office) [Town/District Level Only]서울시 성동구 광나루로Date of Birth or Business Registration No., etc.201-81-49003
Occupation (business)신용카드 제조Relationship to IssuerLargest Shareholder
Business contact and person in chargeAffiliated company(주)바이오스마트Department대외협력팀
Position책 임Phone Number02-321**
Name김혜진Fax number02-321**
Email address**[email protected]

(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)

Legal formCo., Ltd.
Total Assets (or Total Assets Under Management)309,881,100,162Total Liabilities122,224,107,708
Total Equity187,656,992,454Paid-in Capital13,082,219,000
Representative (representative or managing partner)윤호권
Decision-Making Body (Decision Maker)Board of Directors
Largest Shareholder (Largest Investor)박혜린Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)21.21

※ 상기 재무수치는 2025-12-31 연결기준입니다.

b. Specially related parties

(1) Specially related party overview

No.NameCategorySpecific Relationship to ReporterDate of Birth or Business Registration No., etc.NationalityAddress (Location)Occupation (Business)Relationship to Issuer
1옴니시스템(주)Domestic corporationAffiliate130-81-51696Republic of Korea경기도 여주시 가남읍 연삼로제조업Affiliates, etc.
2김혜민Individual (Domestic)Other940712Republic of Korea서울시 서초구 본마을길회사원-
3김형석Individual (Domestic)Other920921Republic of Korea서울시 성동구 성덕정5길회사원-
4박준형Individual (Domestic)Other960207Republic of Korea경기도 용인시 수지구 성복1로회사원-
* Address to town/district level only

(2) Details of specially related parties (for corporations, other entities, statutory or civil-law partnerships)

Legal formCo., Ltd.
Total Assets (or Total Assets Under Management)130,285,749,972Total Liabilities20,141,507,809
Total Equity110,144,242,163Paid-in Capital30,724,677,500
Representative (representative or managing partner)박혜린
Decision-Making Body (Decision Maker)Board of Directors
Largest Shareholder (Largest Investor)㈜바이오스마트Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)33.85

※ 상기 재무수치는 2025-12-31 연결기준입니다.

【특별관계자의 최대주주가 법인, 기타단체, 법령상조합, 민법상 조합의 경우】

Legal formCo., Ltd.
Total Assets (or Total Assets Under Management)309,881,100,162Total Liabilities122,224,107,708
Total Equity187,656,992,454Paid-in Capital13,082,219,000
Representative (representative or managing partner)윤호권
Decision-Making Body (Decision Maker)Board of Directors
Largest Shareholder (Largest Investor)박혜린Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio)21.21

※ 상기 재무수치는 2025-12-31 연결기준입니다.

c. Collective investment manager

(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))

(1) Collective investment manager overview

No.NameBusiness Registration No., etc.Target collective investment vehicleNationalityAddress (Location)Remarks
-------

(2) Collective investment manager details

Legal form-
Paid-in Capital-Total Assets Under Management-
Representative-
Decision-Making Body (Decision Maker)-
Largest Shareholder (Corporate Representative)-Largest Shareholder Stake-

3. Shares, etc. held and holding ratio

Report reference dateReporting personShares, etc.Share CertificatesTotal Issued Voting Shares (shares)
Name of HolderNumber of Specially Related PersonsNumber of Shares, etc. (shares)Ratio (%)Number of Shares (shares)Ratio (%)
Previous Report2026.03.30㈜바이오스마트417,598,89550.2317,598,89550.2335,038,550
This Report2026.11.17㈜바이오스마트420,200,35153.6720,200,35153.6737,640,006
Change2,601,4563.442,601,4563.442,601,456

4. Purpose of holding

Impact on management control
보고자는 자본시장과 금융투자업에 관한 법률 시행령 제154조 제1항 각 호에 대한 사항에대하여 회사의 최대주주로서 회사에 영향력을 행사할 예정입니다.현재 각 호의 사항에 대한 세부 계획은 없지만 회사의 최대주주로서 회사의 업무집행과 관련한 사항이 발생할 경우에는 회사의 경영목적에 부합하도록 관련 행위들을 결정할 예정입니다. 1. 이사 및 감사의 선임ㆍ해임 또는 직무의 정지 2. 이사 및 이사회 등 회사의 기관과 관련된 정관의 변경 3. 회사의 자본금의 변경 4. 회사의 배당의 결정 5. 회사의 합병분할 및 분할합병 6. 주식의 포괄적 교환 및 이전 7. 영업전부의 양수ㆍ양도 또는 금융위원회가 정하여 고시하는 중요한 일부의 양수ㆍ양도 8. 자산의 전부의 처분 또는 금융위원회가 정하여 고시하는 중요한 일부의 처분 9. 영업전부의 임대 또는 경영위임, 타인과 영업의 손익전부를 같이하는 계약, 그밖에 이에 준하는 계약의 체결ㆍ변경 또는 해약10. 회사의 해산

5. Reason for change

Method of change보고자 및 특별관계자의 보유 주식 수 변동
Reason for change제3자배정 유상증자 참여
Reason for Change-

Part 2 Details of Large Holdings

1. Holdings by reporting person and specially related persons

A. Holdings by type of shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Shares Held
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person바이오스마트201-81-4900317,981,865--------17,981,86547.77
Specially Related Party옴니시스템130-81-516961,993,228--------1,993,2285.30
김혜민94071298,503--------98,5030.26
김형석92092178,803--------78,8030.21
박준형96020747,952--------47,9520.13
Aa1a2BCDEFG
H
Total Issued Voting Shares (I)Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H)Holding Ratio (%)
Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100Share Holding Ratio (A / I) × 100
37,640,006-53.6753.67

※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares

B. Holdings by form of holding

RelationshipName (Entity Name)Date of Birth or Business Registration No., etc.Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act)Total
No. 1No. 2No. 3No. 4No. 5No. 6No. 7Number of sharesRatio
Reporting person바이오스마트201-81-4900317,981,865------17,981,86547.77
Specially Related Party옴니시스템130-81-516961,993,228------1,993,2285.30
김혜민94071298,503------98,5030.26
김형석92092178,803------78,8030.21
박준형96020747,952------47,9520.13
※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them

2. Contracts on shares held

A. Contract status

Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.)
None

*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported

B. Contract details

No.Name (Entity Name)Relationship to ReporterDate of Birth or Business Registration No., etc.Type of shares, etc.Number of shares, etc.CounterpartyContract typeContract date (amendment date)Contract periodRatioRemarks
------------
Total (number of shares, etc.)-Total (ratio)--

C. Additional details if the main contract is a security agreement

No.Number of shares, etc.Loan amountDebtorInterest rateCollateral maintenance ratioOther
-------

3. Holdings by proprietary and customer account (financial institutions only)

NameRelationship to ReporterBy accountTotal
Own Account (shares)Ratio (%)Customer account (shares)Ratio (%)Total (shares)Ratio (%)
--------
Total------

Part 3 Material Changes Since Last Report Date

1. Summary of changes

a. Changes in shares, etc.

RelationshipNameDate of Birth or Business Registration No., etc.Details of Changes in Shares, etc.
Share certificatesInstruments representing preemptive rightsConvertible bondsBonds with warrantsExchangeable bondsDepositary receiptsOtherTotal
Voting SharesShares Redeemable into Voting SharesShares Convertible into Voting SharesNumber of sharesRatio (%)
Reporting person바이오스마트201-81-490031,300,728--------1,300,7283.46
Specially Related Party옴니시스템130-81-516961,300,728--------1,300,7283.46
-------------

2. Change details

a. Detailed changes in shares, etc.

(Unit: shares, KRW)
Name (Entity Name)Date of Birth or Business Registration No., etc.Change Date*Acquisition/disposal methodType of shares, etc.Change detailsAcquisition/disposal unit price**Remarks
Before ChangeChangeAfter Change
바이오스마트201-81-490032026.11.17제3자배정유상증자(+)Voting Shares16,681,1371,300,72817,981,8653,844--
옴니시스템130-81-516962026.11.17제3자배정유상증자(+)Voting Shares692,5001,300,7281,993,2283,844--

* For trades on the securities market, the contract date

** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities

3. Source of acquisition funds

(1) Overview of acquisition funds

(Unit: KRW)
NameDate of birth or business registration no., etc.Own funds (H)Borrowings (I)Other (J)Total (H+I+J)
바이오스마트201-81-490034,999,998,432--4,999,998,432
옴니시스템130-81-516964,999,998,432--4,999,998,432

(2) Origin and source of acquisition funds

ㅇ If own funds

NameDate of birth or business registration no., etc.Source and Formation of Acquisition Funds
바이오스마트201-81-49003보유자금
옴니시스템130-81-51696보유자금